Formation and use of poly-L-histidine-catalase complexes by Gibbs, Douglas F. et al.
Inflammation, Vol. 13, No. 4, 1989 
FORMATION AND USE OF POLY-L-H1STIDINE- 
CATALASE COMPLEXES: Protection of Cells 
from Hydrogen Peroxide-Mediated Injury 
D O U G L A S  GIBBS, l JAMES VARANI ,  1 and 
ISAAC GINSBURG 2'3 
~ Department of Pathology 
University of Michigan Medical School 
Ann Arbor, Michigan 48109 
2Department of Oral Biology 
Hebrew University-Hadassah School of Dental Medicine 
Jerusalem, Israel 
3Dr. Isaac Ginsburg was a visiting professor in the Department of Pathology, 
University of Michigan, when this stud)' was done. 
Abstract--Insoluble complexes of poly-L-histidine (polyhistidine) and catalase were 
prepared by mixing the two reactants together in solution at pH 5.5 and subsequently 
elevating the pH to approximately 7.0, at which point they precipitated. Complexes 
formed at optimal ratios of polyhistidine to catatase contained essentially all of the 
catalase present in the original solution. The catalase present in such complexes 
contained greater than 50 % of the H202-inhibiting activity of the native catalase used 
to prepare the complexes. The insoluble complexes rapidly bound to viable endoth- 
elial cells and were resistant to removal by extensive washing. The presence of poly- 
histidine-catalase complexes on the cell surface protected the cells against injury 
mediated by H202 or activated polymorphonuclear Ieukocytes. These data show that 
polyhistidine-catalase complexes can be prepared that have a high affinity for cells 
and that retain catalase activity. These complexes may be useful in treating inflam- 
matory conditions in which it is necessary to maintain a high local concentration of 
inhibitor. 
I N T R O D U C T I O N  
Reactive oxygen metabolites play a central role in a number of inflammatory 
disease processes. In disease processes mediated by polymorphonuclear leu- 
kocytes (PMNs), the inflammatory stimuli trigger the generation of superoxide 
anion (O'2) through activation of the leukocyte membrane NADPH oxidase. 
The O'~- is spontaneously dismutated to hydrogen peroxide (H202), which is 
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then converted to a variety of metabolites. These metabolites, which include 
myeloperoxidase products such as hypochlorous and hypobromous acids, and 
hydroxyl radicals (HO.) generated by ferrous iron reduction of H202 in the 
Fenton reaction, are directly responsible for the tissue injury (reviewed in ref- 
erence 1). 
The importance of H202 as the central reactant in the generation of these 
injurious agents can be deduced from the protective effects afforded by the 
enzyme catalase. Catalase inhibits leukocyte killing of cells in vitro (2-5) and 
protects animals against injury mediated by leukocytes in a number of models 
(6, 7). In both in vitro and in vivo systems, the effectiveness of the treatment 
is limited by the ability of the catalase to localize at the target site. The close 
contact between the effector cells and the target cell is partially responsible for 
this (5, 8). In vivo, this is further complicated by the short circulatory half-life 
of exogenous catalase (9). 
In order to overcome these limitations, chemically modified forms of cat- 
alase have been produced. It has recently been shown that chemical coupling 
of catalase to polyethylene glycol (PEG) allows it to move across the mem- 
branes of cells and thereby increases its internal concentration (10). While mod- 
ification with PEG may be useful for moving catalase across plasma membranes, 
the critical task is to modify the enzyme in such a manner that it can bind to 
cells in the first place. Previous studies from our laboratories have shown that 
polycationic substances can be used to coat a variety of particles and facilitate 
their binding to anionic surface moieties of cells (11, 12). It is possible that a 
polycationic substance would interact with the anionic portions of catalase to 
form complexes, and in the proper ratio promote the binding of the enzyme to 
the cell surface. In the present report we describe the preparation of complexes 
of catalase with the cationic substance poly-L-histidine (polyhistidine). Due to 
their high cationic charge, the complexes readily attach to cell surfaces and 
resist removal by repeated washing. The complexes retain their catalase activity 
and afford complete protection to the cell against HzOz-mediated killing even 
after prolonged incubation and extensive washing. 
M A T E R I A L S  AND METHODS 
Reagents. Minimal essential medium with Earle's salts (MEM), and Hanks' balanced salt 
solution (HBSS) were obtained from Gibco (Grand Island, New York). Fetal bovine serum (FBS), 
penicillin, streptomycin, and fungizone were obtained from K.C. Biological (Lenexa, Kansas). 
The MEM was supplemented with 10% FBS, 100 units/ml of penicillin, 100 /xg/ml of strepto- 
mycin, and 0.25 /~g/ml of fungizone. Potassium thiocyanate, trypsin, polyhistidine (10,800 mol 
wt), H202 (30% solution), and catalase (2800 units/mg) were obtained from Sigma (St. Louis, 
Missouri). Ferrous ammonium sulfate was obtained from Mallinckrodt (Paris, Kentucky). Trichlo- 
Polyhistidine-Catalase Complexes 467 
roacetic acid was obtained from Columbus Chemical Industries (Columbus, Wisconsin). Culture 
dishes and flasks were obtained from Costar (Cambridge, Massachusetts). 
Preparation of Polyhistidine-Catalase Complexes. Complexes consisting of polyhistidine 
and catalase were prepared utilizing four stock solutions: 0.9% saline at pH 5.5-6.0; catalase at a 
concentration of 10 mg/ml in 0.9% saline; polyhistidine at a concentration of 10 mg/ml in 0.9% 
saline, and HBSS buffered with 0.2 M FIEPES buffer at pH 7.35. To prepare the complexes, 0.1 
ml of the stock catalase solution was first added to 0.4 ml of the saline solution. While vortexing, 
various amounts of the polyhistidine solution were added. Upon addition of the polyhistidine, the 
solution became opalescent, although a true precipitate did not form. While still vortexing, enough 
of the HEPES-buffered HBSS was added to bring the final volume to 1.0 ml. The addition of the 
HEPES-buffered HBSS brought the pH of the solution to approximately 7.0, at which point a true 
precipitate formed. The mixture was allowed to stand for 5 min, after which the polyhistidine- 
catalase complexes were pelleted by centrifugation and washed two times. After the second wash, 
the pellet was resuspended in 1.0 ml of  HBSS and tested for catalase activity as described below. 
Endothelial Cells. Pulmonary artery endothelial cells were obtained from rat lungs as 
described elsewhere (13). They were ide~tified as endothelial cells by the presence of angiotensin- 
converting enzyme activity, reactivity with antibodies to factor VIII and c~2-macrogtobulin, and by 
typical electron microscopic features. The cells were cultured as monolayers in MEM with 10% 
FBS and antibiotics in 150-cm 2 flasks at 37~ and 5% CO2. When confluency was reached, the 
cells were subcultured after retrieval with a rubber policeman. The cells were routinely used through 
passage 35. 
Quantitation of H20~ and Catalase Activity. H2Q was measured using reduction of ferrous 
ammonium sulfate as indicator (14). A standard curve was established for each experiment and 
catalase activity was measured by dismutation of known quantities of H202. Catalase activity asso- 
ciated with the polyhistidine-catalase complexes was assessed by comparison to a standard curve 
generated with native catalase. 
Cytotoxicity Assay. Endothelial cells were seeded into wells of a 24-well plate in 1 ml of 
MEM containing 10% FBS at a density of 1 x 105 cells/well. The plate was then incubated over- 
night at 37~ in 5% CO2, during which time the cells formed confluent monolayers. At the start 
of  the assay, the cells were washed three times in MEM and then appropriate reactants, i.e., native 
catalase or polyhistidine-catalase complexes, were added in a final volume of 1.0 ml/well. In 
certain experiments the plates were centrifuged at 400g for 5 rain to promote interaction of the 
complexes with the cells. This was not essential, however, as the polyhistidine-catalase complexes 
would bind to the cells without centrifugation. Except where noted, the cells were then washed 
five times with MEM. Following this, various amounts of H202 in MEM were added to give a 
final volume of 1.0 ml/well. The H2Oz-treated cells were incubated at 37~ and 5% CO2 for 1 h. 
At the end of 1 h, residual H202 was inactivated by addition of excess catalase (1800 units/ml), 
and the cells were harvested with 0.2 % trypsin. The harvested cells were centrifuged, resuspended 
in MEM with 10% FBS, and reseeded into the larger six-well (35 mm diameter) culture dishes. 
After overnight incubation at 37~ and 5% COs, the cells were washed once with 0.9% saline to 
remove debris, harvested in 0.5 ml of trypsin (0.2%), and counted with a Coulter counter. By 
comparing the number of cells harvested after the final incubation with the number originally exposed 
to HzO2, we were able to obtain a measure of the percentage killed. 
A S~Cr-retease assay was used to measure neutrophil-mediated killing of endothelial cells. 
Human peripheral blood leukocytes were obtained from healthy adult volunteers, and the poly- 
morphonuclear leukocytes were isolated by dextran sedimentation followed by density gradient 
centrifugation through Ficoll-Hypaque medium. The cells obtained were approximately 98% poly- 
morphonuclear granulocytes. Endothelial cells were seeded into wells of a 24-well plate as described 
above and labeled with 2 /zCi of  S~Cr per well. One day later, the cells were washed to remove 
unincorporated 5~Cr and incubated with polyhistidine-catalase complexes as described above~ After 
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removal of nonbound complexes, treated and control cells were exposed to neutrophils at a 10 : 1 
effector-to-target ratio. The neutrophils were activated with phorbol myristate acetate (PMA) at a 
concentration of 100 ng/ml. Cytotoxicity (5~Cr release) was assessed after 4 or 18 h. The 5~Cr- 
release assay is described in detail in our previous reports (5, 15). 
RESULTS 
Preparation and Assay of Polyhistidine-Catalase Com- 
plexes. Complexes of polyhistidine and catalase were prepared by varying the 
amount of polyhistidine while keeping the catalase constant. After formation, 
the complexes were removed by centrifugation and the amount of catalase 
incorporated into the complexes determined. Concomitantly, the amount of cat- 
alase remaining in solution was also determined. Table 1 shows the distribution 
of catalase after formation of polyhistidine-catalase complexes at three ratios 
of polyhistidine to catalase. When 0.1 mg of polyhistidine was used with 1.0 
mg of catalase, the complexes contained approximately 17% of the catalase 
originally present with approximately 83 % remaining in solution. When com- 
plexes were formed with 0.5 or 1.0 mg of polyhistidine per milligram of cata- 
lase, the complexes contained 50-58% of the catalase originally present. 
However, under these conditions, there was essentially no residual catalase 
remaining in solution. This suggests that all of the catalase was incorporated 
into the complexes but that some of the catalase was inactivated by the high 
concentration of polyhistidine. Figure 1 compares the H202-inhibiting activity 
of native catalase and catalase complexed with polyhistidine. 
In additional experiments, higher-molecular-weight polyhistidine prepa- 
rations (e.g., 15,000 and 20,000 mol wt) were used. When these were used, it 
Table 1. Incorporation of Catalase into Complexes Formed with Polyhistidine 
Amount (p,g) of catalase 
Reactants used" recovered ~' 
Polyhistidine Catalase Complex Solution 
100 1000 174 889 
500 1000 579 0 
1000 1000 505 0 
Complexes of polyhistidine and catalase were formed by mixing increasing amounts 
of  polyhistidine with a constant amount of catalase as described in the Methods section. 
bThe amount of  catalase recovered was determined based on activity (H202 inhibition), 
comparing the amount of  activity in the complexes and in solution with the amount of  
activity present in known quantities of  native catalase. The values are from a single 
experiment. The experiment was repeated three times with similar results. 
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Fig. 1. Assessment of catalase activity in polyhistidine-catalase complexes. A 30% stock solution 
of H202 was diluted and assayed using reduction of ferrous ammonium sulfate as the indicator. 
Based on this, a stock solution containing 2000 nmol H202/ml was prepared. The stock H202 
solution was incubated for 10 min with various amounts of native catalase or polyhistidine-catalase 
complexes and residual H202 determined. Values shown represent inhibition of ferrous ammonium 
sulfate reduction by H202 after incubation with native or complexed catalase. Values are means 
and standard deviations based on triplicate samples in a single experiment. The experiment was 
repeated five times with similar results. 
required a correspondingly greater amount of  polyhistidine (on a per microgram 
basis) to produce complexes containing comparable amounts of  catalase. The 
maximal catalase activity incorporated into these complexes was always less 
than the amount incorporated into complexes formed with 10,800 mol wt poly- 
histidine (not shown). This suggests greater inactivation of  the catalase when 
complexed to the higher-molecular-weight polyhistidine preparations. 
Experiments were also conducted with catalase preparations containing 
greater amounts o f  catalase activity per milligram of  protein. Polyhistidine- 
catalase complexes formed with these catalase preparations contained corre- 
spondingly greater amounts of  catalase activity (not shown). 
Binding of Polyhistidine-Catalase Complexes to Surface of Endothelial 
Cells. When monolayers of  endothelial cells were treated in culture with the 
polyhistidine-catalase complexes, the complexes rapidly bound to the cell sur- 
face. This could be assessed visually under phase-contrast microscopy. The 
interaction of  the complexes with cells could be accelerated by centrifuging the 
monolayers after addition of  the complexes, and this was routinely done. How- 
ever, it was not essential, as the precipitated complexes would settle onto the 
cells and bind to them without centrifugation. To quantitate the amount of  cat- 
alase bound to the cell surface, the cells were treated with the complexes and 
centrifuged. Following this, the monolayers were washed five times and each 
of  the washes assessed for catalase activity. No detectable catalase activity was 
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present in any of the washes. This suggests that once bound, the polyhistidine- 
catalase complexes were not readily released by the cells. In addition to mea- 
suring catalase activity released from the cell surface by washing, the amount 
of activity remaining on the cell surface was also measured. The total amount 
of activity remaining after five washes was approximately 25 % of the amount 
added to the cells. These data are summarized in Table 2. It may be inferred 
by the lack of activity in the washes that most of the loss in activity was a result 
of enzyme inactivation due to interaction with the cell membrane. Alternatively, 
the reduction in detectable activity on the cell surface may reflect internalization 
of the polyhistidine-catalase complexes. Although no experiments were done 
to determine if the complexes were intemalized, previous studies from our lab- 
oratory have shown that a variety of cationic complexes are readily internalized 
by cells in culture (11, 16). 
Protection of Endothelial Cells from H202-Mediated Killing by Polyhisti- 
dine-Catalase Complexes. Rat pulmonary artery endothelial cells were exam- 
ined for sensitivity to killing by H202. Figure 2 indicates that under t h e  
conditions of the experiment, 100 nmol of H202 induced killing of approxi- 
mately 50% of the endothelial cells in 1 h. In the presence of 400 nmol of 
H202, virtually 100% of the cells were killed. Figure 2 also demonstrates the 
ability of the polyhistidine-catalase complexes to protect the target cells from 
Table 2. Binding of Polyhistidine-Catalase Complexes to Surface of 
Endothelial Cells 
Amount of catalase 
Group a recovered h (#g) % of total 
Total amount added 2.90 100 
Amount recovered in wash 
1 <0105 <2  
2 <0.05 <2  
3 <0.05 <2  
4 <0.05 <2  
5 <0.05 < 2  
Amount remaining on cells 
after five washes 0.70 25 
~Monolayers of endothelial cells (1 • 10 5 cells in 1 ml) were incubated 
with polyhistidine-catalase complexes containing eatalase activity 
equivalent to 2.9 #g of native catalase. The culture medium was then 
removed (wash 1) and the monolayer washed four additional times. Each 
of the washes and the monolayers was assessed for catalase activity. 
bThe amount of catalase recovered was determined based on activity, 
comparing the amount of activity in each fraction to the amount of activ- 
ity in known quantities of native catalase. The values are from a single 
experiment. The experiment was repeated three times with similar results. 
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Fig. 2. (A) Concentration-dependent killing of endothelial cells by H202. Endothelial cells were 
exposed to varying amounts of HzO 2 for 1 h as described in Materials and Methods9 Following 
this, the percentage of cells that were incapable of replating was determined. (B) Protection of 
endothelial cells from HzOz-mediated killing by native catalase and polyhistidine-catalase com- 
plexes. Endothelial cells were treated with varying amounts of native catalase or polyhistidine- 
catalase complexes. After incubation for 10 min, the nonbound catalase was removed by washing 
five times9 The cells were then exposed to 1000 nmol H202/ml and incubated for 1 h. Following 
this, the percentage of cells that were incapable of replating was determined. Values shown are 
means and standard deviations based on triplicate samples in a single experiment. The experiment 
was repeated five times with similar results. 
H2Q-media ted  killing after extensive washing. For this experiment, endothelial 
cells were incubated with various amounts of  the complexes for 10 min. Cells 
treated with native catalase served as a control. After the initial incubation 
period, the endothelial cells were washed five times to remove catalase not 
bound to the cells and then exposed to 1000 nmol of  H202. Under these con- 
ditions, protection was obtained with as little as 2 /xg of  the polyhistidine- 
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Table 3. Protection against PMN-Mediated Injury to Endothelial Cells by Polyhistidine-Catalase 
Complexes" 
4 hours 18 hours 
Specific Specific 
cytotoxicity cytotoxicity 
Treatment CPM (%) CPM (%) 
None 915 _+ 11 4 7885 _+ 998 33 
Polyhistidine-catalase 651 _+ 8 0 5502 _+ 650 24 
a Endothelial cells were treated with polyhistidine-catalase complexes containing approximately 1 
/tg of catalase. After incubation with the complexes for 10 min, the monolayers were washed five 
times to remove nonbound complexes. Following this, treated and control monolayers were incu- 
bated with neutrophils (10:1 effector-target ratio), which were activated 15 min later by addition 
of 100 ng of PMA/well. 5tCr release from control and treated monolayers was measured 4 h or 
18 h later. 
bValues shown represent the average specific 5~Cr released + standard errors based on seven inde- 
pendent experiments for the 4-h assay and 11 independent experiments for the 18-h assay. The 
percent specific cytotoxicity was calculated based on the following formula: 
Specific cytotoxicity (%) = experimental release - spontaneous release/total release - sponta- 
neous release. 
catalase complexes. Protection was dose-responsive over the range of 0-10/xg. 
In contrast, no protection was seen with 25 tzg of native catalase under the same 
conditions. 
Polyhistidine-catalase complexes were next examined for ability to protect 
endothelial cells from activated neutrophils. Past studies by several groups have 
shown that endothelial cell killing by activated neutrophils is HzO2-dependent 
(2-5). Table 3 summarizes 51Cr-release data from several independent experi- 
ments. Neutrophils activated with PMA produced a net increase in 51Cr release 
over the amount released by endothelial cells alone or endothelial cells incu- 
bated with nonactivated PMNs. Virtually 100% of the killing in the 4-h assay 
was inhibited by treatment of the cells with 2/zg of the polyhistidine-catalase 
complexes followed by extensive washing. Endothelial cell killing in the 18-h 
assay was also inhibited by the polyhistidine-catalase complexes. Although the 
degree of protection was much less after 18 h, this is probably attributable to 
the fact that killing in the 18-h assay is due, in part, to protease activity (unpub- 
lished observation). 
DISCUSSION 
This study describes the preparation of polyhistidine-catalase complexes 
and the ability of these complexes to bind to the surface of endothelial cells and 
protect them from H202-mediated killing. The chemistry of complex formation 
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involves electrostatic interaction between the highly cationic polyhistidine with 
anionic sites on the catalase molecule and precipitation of the complexes at 
neutral pH. Formation of the complexes is rapid and easy. The stock reagents 
used to prepare the complexes are stable for several days at 4~ and the com- 
plexes themselves are also stable for several days at 4~ after preparation. 
Complexes formed to provide optimal amounts of catalase activity (determined 
by mixing various amounts of polyhistidine with a constant amount of catalase) 
incorporated virtually 100 % of the available catalase under conditions in which 
a high degree of the catalase activity (greater than 50%) was retained. Prepa- 
ration of complexes with a lower ratio of polyhistidine to catalase resulted in 
less of the catalase being incorporated into the complexes and complexes formed 
with a higher polyhistidine to catalase ratio had reduced enzymatic activity. 
The polyhistidine-catalase complexes readily bound to the surface of 
endothelial cells and resisted removal by washing. The presence of complexes 
on the cell surface provided a high degree of protection against injury mediated 
by H202 directly or mediated by activated neutrophils. The ability to bind cat- 
alase to the surface of cells may provide a useful means for protecting cells 
from H202-mediated injury under a variety of conditions. Native catalase can 
protect cells in vitro from PMN-induced injury, but the degree of protection is 
limited by the fact that activated neutrophils adhere tightly to the target cell 
surface (5) and exclude fluid-phase inhibitors from the active site (8). Catalase 
can also protect animals against inflammatory processes mediated by neutro- 
phils (6, 7). Protection against in vivo injury suffers from the same limitations 
as exist in vitro and is further limited by the short half-life of circulating catalase 
(9). By treating the target cells with a reagent that binds tightly to the cell 
surface, it may be possible to obtain a high specific activity of inhibitor at the 
site of attack. In this respect it is of note that cationization of catalase and 
horseradish peroxidase by the carbidiimide method was found to suppress the 
inflammatory response in two types of experimental arthritis in the mouse (17). 
Such cationized enzymes were also found to be retained in the joint tissues for 
much longer periods, as compared to native enzymes. 
Finally, although all of the data presented in this report relate to the use 
of complexes formed with the enzyme catalase, it should be possible to prepare 
insoluble complexes of polyhistidine with other proteins as well. Using the same 
general approach as described here, we have prepared complexes of superoxide 
dismutase and polyhistidine and complexes of soybean trypsin inhibitor and 
polyhistidine. These complexes also retain their catalytic and inhibitory activ- 
ities. The simplicity with which the complexes can be formed make this method 
potentially amenable to a variety of uses. 
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